Fig. 1From: Benefits of near-universal vaccination and treatment access to manage COVID-19 burden in the United StatesAnnual cases, hospitalizations, and deaths between 2025 and 2033 under varying vaccination coverages in three transmission scenarios and three immune durations. The current vaccination coverage is 49%. The treatment coverage through the entire period is 13.7%Back to article page